United Kingdom · Question · Written question
HL HL8484
Voluntary Scheme for Branded Medicines Pricing and Access
Introduced
14 June 2023
Last action
—
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 June 2023
Summary
To ask His Majesty's Government what assessment they have made of whether any disinvestment decisions have been taken in the UK because of the rebates imposed on companies through the Voluntary Scheme for Branded Medicines Pricing and Access.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.